Clinical trials
Completed Renal Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
899 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 28 |
| 2004 | 25 |
| 2005 | 18 |
| 2006 | 30 |
| 2007 | 24 |
| 2008 | 54 |
| 2009 | 36 |
| 2010 | 50 |
| 2011 | 58 |
| 2012 | 43 |
| 2013 | 45 |
| 2014 | 42 |
| 2015 | 44 |
| 2016 | 42 |
| 2017 | 52 |
| 2018 | 35 |
| 2019 | 39 |
| 2020 | 23 |
| 2021 | 39 |
| 2022 | 36 |
| 2023 | 40 |
| 2024 | 38 |
| 2025 | 16 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 899 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 24 |
| AstraZeneca | 19 |
| Merck Sharp & Dohme LLC | 17 |
| Pfizer | 16 |
| Astellas Pharma Inc | 13 |
| Akebia Therapeutics | 11 |
| GlaxoSmithKline | 11 |
| Bayer | 10 |
| Boehringer Ingelheim | 10 |
| Fresenius Medical Care Deutschland GmbH | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 899 |
| Kidney Failure, Chronic | 112 |
| Renal Insufficiency, Chronic | 96 |
| Kidney Diseases | 85 |
| Heart Failure | 45 |
| Acute Kidney Injury | 41 |
| Anemia | 33 |
| Diabetes Mellitus, Type 2 | 26 |
| Diabetes Mellitus | 22 |
| Multiple Myeloma | 19 |
Trials
Showing 1 to 25 of 899. Each trial links to its page on Pharma Observatory.
799 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.